Healthcare International is Transforming Treatment for Rare Cancers
When people think of cancer, names like breast, lung, or prostate cancer usually come to mind. But what about the less common cancers that quietly affect thousands of people worldwide?
These are rare cancers — unique, challenging, and often misunderstood. At Healthcare International (HCI), we believe every cancer, no matter how rare, deserves attention, advanced treatment, and compassion.
What Are Rare Cancers?
A cancer is considered “rare” when it affects fewer than 6 people out of 100,000 each year.
Examples include:
- Sarcomas (cancer of bones and soft tissues)
- Neuroendocrine tumors (NETs)
- Mesothelioma (linked to asbestos exposure)
- Thymus cancer
- Rare gynecological and pediatric cancers
Though uncommon, together they make up about 20–25% of all cancer cases.
Why Are Rare Cancers So Challenging?
- Delayed Diagnosis
Because symptoms mimic common illnesses, rare cancers are often diagnosed late.
- Limited Research
Fewer cases mean fewer studies and fewer clinical trials.
- Treatment Uncertainty
Many rare cancers don’t have standardized protocols like breast or lung cancer do.
- Access to Experts
Specialist centers for rare cancers may be limited or unavailable in many regions.
How HCI Supports Patients with Rare Cancers
At Healthcare International, we ensure rare cancer patients are never left behind:
- Early and precise diagnosis using PET-CT, MRI, and genetic profiling
- Access to expert oncologists with rare cancer experience
- Advanced therapies like targeted drugs, immunotherapy, proton therapy, and robotic surgery
- Global treatment options through our international hospital network
- Personalized care plans designed for unique cases
Stories of Strength
Dilnoza Karimova from Uzbekistan was diagnosed with a rare cancer that left her family confused and fearful, as local doctors had limited answers. At Healthcare International, she finally found clarity through advanced diagnostics and a personalized treatment plan tailored to her condition. Today, Dilnoza is responding well and feels hopeful again. “For the first time, I felt like my battle was understood. HCI gave me both treatment and confidence,” she shared.
Rare cancers may be uncommon, but the courage of patients who face them is extraordinary. At HCI, we are committed to bringing the latest research, best technology, and most compassionate care to every rare cancer journey.
Call, Message or WhatsApp us for appointments.
Healthcare International, your trusted partner for the best medical treatments